How a Research Lab Made Entirely of LLM Agents Developed Molecules That Can Block a Virus
SMRTR summary
A team of GPT-4o AI agents, each assigned specific scientific roles, successfully developed experimentally validated nanobodies that can bind to recent SARS-CoV-2 variants. The AI researchers designed and executed a complete research process—from strategy development to computational analysis—with minimal human intervention, producing 92 testable molecules with effectiveness similar to traditional human-led research but in significantly less time.
SMRTR provides this summary for quick context. The original article belongs to Daily.dev.
Read the original article